The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 03, 2015

Filed:

Oct. 16, 2012
Applicant:

Haifeng Chen, Piedmont, CA (US);

Inventor:

Haifeng Chen, Piedmont, CA (US);

Assignee:

Virovek Incorporation, Hayward, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07H 21/00 (2006.01); C12N 15/86 (2006.01); A61K 31/7088 (2006.01); C07K 14/34 (2006.01); C07K 14/21 (2006.01); C12N 9/22 (2006.01); C12N 9/24 (2006.01); A61K 48/00 (2006.01);
U.S. Cl.
CPC ...
C12N 15/86 (2013.01); A61K 31/7088 (2013.01); C07K 14/21 (2013.01); C07K 14/34 (2013.01); C12N 9/22 (2013.01); C12N 9/2497 (2013.01); A61K 48/00 (2013.01); C12N 2710/14043 (2013.01); C12N 2710/14052 (2013.01); C12N 2750/14143 (2013.01); C12N 2750/14152 (2013.01); C12N 2799/026 (2013.01); C12N 2830/42 (2013.01); C12N 2840/005 (2013.01); C12N 2840/102 (2013.01); C12N 2840/44 (2013.01); C12N 2840/85 (2013.01);
Abstract

The present disclosure describes nucleic acids, and viruses comprising such nucleic acids, for growing a toxic gene in an insect cell. These nucleic acids comprise a sequence encoding a toxic polypeptide, and an intron that interrupts the sequence, whereby the intron is spliced in mammalian cells but not in insect cells. Infection of mammalian cells but not insect cells with the nucleic acids or viruses can lead to expression of toxic levels of the toxic polypeptide in mammalian cells but not in insect cells. Viruses, such as an AAV or a baculovirus comprising a nucleic acid can be grown in insect cell lines in vitro and can be administered to a subject in need of therapy, such as a subject in need of cancer therapy.


Find Patent Forward Citations

Loading…